Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Eur J Anaesthesiol
Tirzepatide's dual receptor mechanism How tirzepatide works: Dual GIP/GLP-1 receptor agonist Single molecule, two pathways GIP (glucose-dependent insulinotropic polypeptide) + GLP-1 Weekly subcutaneous injection FDA approved for diabetes and obesity GIP pathway effects: Enhances insulin secretion Improves insulin sensitivity Promotes fat metabolism Reduces inflammation Works synergistically with GLP-1 GLP-1 pathway effects: Suppresses appetite (central brain effects) Slows gastric emptying (moderate) Increases satiety Reduces glucagon Improves glucose control Combined tirzepatide results: 15-22% average body weight loss (monotherapy) Superior to semaglutide (GLP-1 alone) Well-tolerated in trials Approved and available See our tirzepatide dosing guide , semaglutide vs tirzepatide , and peptides for weight loss at SeekPeptides
Verify authorization requirements before administering the drug, not after the claim comes back denied
Mechanism of Action: DSIP acts on the central nervous system, helping to modulate sleep-wake cycles, particularly enhancing deep (delta) sleep
10.1111/j.1600-051x.1984.tb00840.x Xuan B, Zhou YH, Li N, Min ZD, Chiou GC: Effects of crocin analogs on ocular blood flow and retinal function
pylori ) (8)
